CD8A and non-small cell lung carcinoma: However, the findings of a further study have indicated that high levels of circulating CD8+PD-1+ T cells have a positive influence on the prognosis of patients with immune checkpoint inhibitor (ICI)-treated advanced NSCLC (15).